BORTHWICK KATHLEEN (SVP, Interim CFO) sold 29.2% of their position (10.67K shares) of PASSAGE BIO, INC. on the open market
Open‑market sale worth $9.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/3/2024ACC: 0001209191-24-000367
Officer· SVP, Interim CFO
Since Jul 2023
-10.67K
Net shares
Net seller
$9.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30K acquired · 40.67K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
454.0%
12/31/2023
6.61K→36.61K
Common Stock
Direct
Shares
−10.67K
Price / share
$0.91
Trade value
$9.71K
% of position
29.2%
1/2/2024
36.61K→25.94K
Total
Net shares
+19.33K
Net value
-$9.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2023 | M · Option Exercise | +30K | — | — | 454.0% | 6.61K | 36.61K |
| Common Stock Direct | 1/2/2024 | S · Sale | −10.67K | $0.91 | $9.71K | 29.2% | 36.61K | 25.94K |
| Total | +19.33K | -$9.71K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
30K shares
Shares
−30K
Strike price
Held after
0.00
Exercisable
—
12/31/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock30K shares | 12/31/2023 | M · Option Exercise | −30K | — | 0.00 |